{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:57:50Z","timestamp":1793408270325,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05112-5","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:13:51Z","timestamp":1774437231000},"page":"4253-4278","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Global epidemiology of hepatitis B virus infection in dialysis patients: a systematic review and meta-analysis of prevalence, immunity, risk factors, and beyond"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9594-6857","authenticated-orcid":false,"given":"Alif Hasan","family":"Pranto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-7994","authenticated-orcid":false,"given":"Ehsan","family":"Suez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Ekhtiar","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3780-0367","authenticated-orcid":false,"given":"Hasan Shahriyer","family":"Tonmoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. M. Rubaiyat Muntasir","family":"Meem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6985-4087","authenticated-orcid":false,"given":"Fahim","family":"Montasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Nourin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2739-6707","authenticated-orcid":false,"given":"Shifaty Nur","family":"Abir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0023-1733","authenticated-orcid":false,"given":"Dewan Zubaer","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed","family":"Ajmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahima","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4724-0645","authenticated-orcid":false,"given":"Shahad Saif","family":"Khandker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"issue":"8","key":"5112_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH (2023) Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol 20(8):524\u2013537","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"S5","key":"5112_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ (2009) Hepatitis B: the virus and disease. Hepatology 49(S5):S13\u2013S21","journal-title":"Hepatology"},{"issue":"3","key":"5112_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/v13030368","volume":"13","author":"T Pollicino","year":"2021","unstructured":"Pollicino T, Caminiti G (2021) HBV-integration studies in the clinic: role in the natural history of infection. Viruses 13(3):368","journal-title":"Viruses"},{"issue":"26","key":"5112_CR4","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.3748\/wjg.v27.i26.4182","volume":"27","author":"P Veronese","year":"2021","unstructured":"Veronese P et al (2021) Prevention of vertical transmission of hepatitis B virus infection. World J Gastroenterol 27(26):4182","journal-title":"World J Gastroenterol"},{"key":"5112_CR5","unstructured":"CDC. Clinical Overview of Hepatitis B. 2025 [cited 2025 25 January]; Available from: https:\/\/www.cdc.gov\/hepatitis-b\/hcp\/clinical-overview\/index.html."},{"key":"5112_CR6","unstructured":"WHO. Hepatitis B. 2025 [cited 2026 25 January]; Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"5112_CR7","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S291976","author":"T Broquetas","year":"2022","unstructured":"Broquetas T, Carri\u00f3n JA (2022) Current perspectives on nucleos(t)ide analogue therapy for the long-term treatment of Hepatitis B virus. Hepat Med Evid Res. https:\/\/doi.org\/10.2147\/HMER.S291976","journal-title":"Hepat Med Evid Res"},{"issue":"5","key":"5112_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4254\/wjh.v15.i5.585","volume":"15","author":"II Salama","year":"2023","unstructured":"Salama II et al (2023) Current and novel modalities for management of chronic hepatitis B infection. World J Hepatol 15(5):585","journal-title":"World J Hepatol"},{"issue":"2","key":"5112_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3138\/canlivj-2025-0012-e","volume":"8","author":"CPGC Chair","year":"2025","unstructured":"Chair CPGC et al (2025) The management of chronic hepatitis B: 2025 guidelines update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada. Canadian Liver J 8(2):368\u2013401","journal-title":"Canadian Liver J"},{"issue":"1","key":"5112_CR10","doi-asserted-by":"publisher","first-page":"2541873","DOI":"10.1080\/0886022X.2025.2541873","volume":"47","author":"W Chancharoenthana","year":"2025","unstructured":"Chancharoenthana W et al (2025) Optimizing hepatitis B vaccination in chronic kidney disease: a comprehensive scoping review of strategies across CKD stages, dialysis, and transplant populations. Ren Fail 47(1):2541873","journal-title":"Ren Fail"},{"issue":"1","key":"5112_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14760584.2023.2289566","volume":"23","author":"J Qiu","year":"2024","unstructured":"Qiu J et al (2024) Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. Expert Rev Vaccines 23(1):69\u201381","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"5112_CR12","volume":"9","author":"S Vadakedath","year":"2017","unstructured":"Vadakedath S, Kandi V (2017) Dialysis: a review of the mechanisms underlying complications in the management of chronic renal failure. Cureus 9(8):e1603","journal-title":"Cureus"},{"key":"5112_CR13","first-page":"2002","volume":"2010","author":"MA Abbasi","year":"2010","unstructured":"Abbasi MA, Chertow GM, Hall YN (2010) End-stage renal disease. BMJ Clin Evid 2010:2002","journal-title":"BMJ Clin Evid"},{"issue":"1","key":"5112_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.kisu.2021.11.003","volume":"12","author":"CP Kovesdy","year":"2022","unstructured":"Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12(1):7\u201311","journal-title":"Kidney Int Suppl"},{"key":"5112_CR15","unstructured":"CDC. Kidney Disease Surveillance System. 2023 [cited 2026 25 January]; Available from: https:\/\/wwwn.cdc.gov\/kdss\/."},{"issue":"2_suppl","key":"5112_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/089686080302302s22","volume":"23","author":"K-C Tse","year":"2003","unstructured":"Tse K-C, Lui S-L, Lo W-K (2003) Comparison of long-term survival (beyond 12 years) in patients on peritoneal dialysis and on hemodialysis. Perit Dial Int 23(2_suppl):104\u2013108","journal-title":"Perit Dial Int"},{"issue":"2","key":"5112_CR17","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2215\/CJN.04000422","volume":"18","author":"RJ Chan","year":"2023","unstructured":"Chan RJ et al (2023) Management of intermittent hemodialysis in the critically ill patient. Clin J Am Soc Nephrol 18(2):245\u2013255","journal-title":"Clin J Am Soc Nephrol"},{"key":"5112_CR18","doi-asserted-by":"publisher","DOI":"10.1590\/1677-5449.202300522","volume":"22","author":"LdO Harduin","year":"2023","unstructured":"Harduin LdO et al (2023) Guidelines on vascular access for hemodialysis from the Brazilian Society of Angiology and Vascular Surgery. J Vasc Bras 22:e20230052","journal-title":"J Vasc Bras"},{"key":"5112_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2024.1322493","volume":"15","author":"RT Krediet","year":"2024","unstructured":"Krediet RT (2024) Physiology of peritoneal dialysis; pathophysiology in long-term patients. Front Physiol 15:1322493","journal-title":"Front Physiol"},{"issue":"6","key":"5112_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/ckj\/sft122","volume":"6","author":"RT Krediet","year":"2013","unstructured":"Krediet RT (2013) Peritoneal dialysis: from bench to bedside. Clin Kidney J 6(6):568\u2013577","journal-title":"Clin Kidney J"},{"key":"5112_CR21","first-page":"CD003963","volume":"4","author":"L Vale","year":"2004","unstructured":"Vale L et al (2004) (2004) Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults. Cochrane Database Syst Rev 4:CD003963","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"5112_CR22","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1177\/106002809202601115","volume":"26","author":"GR Bailie","year":"1992","unstructured":"Bailie GR, Eisele G (1992) Continuous ambulatory peritoneal dialysis: a review of its mechanics, advantages, complications, and areas of controversy. Ann Pharmacother 26(11):1409\u20131420","journal-title":"Ann Pharmacother"},{"issue":"2","key":"5112_CR23","first-page":"OC05","volume":"10","author":"AO Kayalar","year":"2016","unstructured":"Kayalar AO et al (2016) Comparison of long-term complications in patients on haemodialysis and peritoneal dialysis longer than 10 years. J Clin Diagn Res 10(2):OC05","journal-title":"J Clin Diagn Res"},{"key":"5112_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneph.2023.1198560","volume":"3","author":"G Echefu","year":"2023","unstructured":"Echefu G et al (2023) Pathophysiological concepts and screening of cardiovascular disease in dialysis patients. Front Nephrol 3:1198560","journal-title":"Front Nephrol"},{"issue":"6","key":"5112_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286579","volume":"18","author":"W Bitar","year":"2023","unstructured":"Bitar W et al (2023) Severe infections in peritoneal dialysis and home hemodialysis patients: an inception cohort study. PLoS ONE 18(6):e0286579","journal-title":"PLoS ONE"},{"issue":"13","key":"5112_CR26","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.3390\/jcm11133759","volume":"11","author":"S Campo","year":"2022","unstructured":"Campo S et al (2022) Immune system dysfunction and inflammation in hemodialysis patients: two sides of the same coin. J Clin Med 11(13):3759","journal-title":"J Clin Med"},{"issue":"5","key":"5112_CR27","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.2215\/CJN.00950208","volume":"3","author":"S Kato","year":"2008","unstructured":"Kato S et al (2008) Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 3(5):1526\u20131533","journal-title":"Clin J Am Soc Nephrol"},{"key":"5112_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/2054358119839080","volume":"6","author":"C Lamarche","year":"2019","unstructured":"Lamarche C, Iliuta I-A, Kitzler T (2019) Infectious disease risk in dialysis patients: a transdisciplinary approach. Can J Kidney Health Dis 6:2054358119839080","journal-title":"Can J Kidney Health Dis"},{"key":"5112_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01477","volume":"11","author":"MA Islam","year":"2020","unstructured":"Islam MA et al (2020) Immunomodulatory effects of diet and nutrients in systemic lupus erythematosus (SLE): a systematic review. Front Immunol 11:1477","journal-title":"Front Immunol"},{"issue":"1","key":"5112_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/14737140.2025.2557615","volume":"26","author":"A Mustafa","year":"2026","unstructured":"Mustafa A et al (2026) Epstein-Barr virus (EBV) infection and associated post transplantation lymphoproliferative disease (PTLD) in hematopoietic stem cell transplantation (HSCT): a prevalence based systematic review and meta-analysis on global epidemiology. Expert Rev Anticancer Ther 26(1):105\u2013117","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"5112_CR31","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1097\/MS9.0000000000001649","volume":"86","author":"MK Saleem","year":"2024","unstructured":"Saleem MK et al (2024) Use of telemedicine to tackle health problems in South Asia during the COVID-19 era and beyond: a systematic review. Ann Med Surg (Lond) 86(2):1012\u20131020","journal-title":"Ann Med Surg (Lond)"},{"issue":"11","key":"5112_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102392","volume":"18","author":"MA Islam","year":"2019","unstructured":"Islam MA et al (2019) Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun Rev 18(11):102392","journal-title":"Autoimmun Rev"},{"key":"5112_CR33","unstructured":"NIH. Study Quality Assessment Tools. 2021 [cited 2023 22 September]; Available from: https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools."},{"key":"5112_CR34","unstructured":"UNC. Systematic Reviews: Step 6: Assess Quality of Included Studies. 2023 [cited 2023 22 September]; Available from: https:\/\/guides.lib.unc.edu\/systematic-reviews\/assess-quality."},{"issue":"9","key":"5112_CR35","volume":"17","author":"YA Malik","year":"2025","unstructured":"Malik YA et al (2025) Association of Anticardiolipin Antibody in Myocardial Infarction: A Systematic Review and Meta-Analysis. Cureus 17(9):e91474","journal-title":"Cureus"},{"issue":"3","key":"5112_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/thalassrep13030018","volume":"13","author":"SS Khandker","year":"2023","unstructured":"Khandker SS et al (2023) Association between glomerular filtration rate and \u03b2-thalassemia major: a systematic review and meta-analysis. Thalassemia Rep 13(3):195\u2013205","journal-title":"Thalassemia Rep"},{"issue":"16","key":"5112_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163493","volume":"10","author":"SS Khandker","year":"2021","unstructured":"Khandker SS et al (2021) Diagnostic accuracy of rapid antigen test kits for detecting SARS-CoV-2: a systematic review and meta-analysis of 17,171 suspected COVID-19 patients. J Clin Med 10(16):3493","journal-title":"J Clin Med"},{"issue":"1","key":"5112_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227836","volume":"15","author":"MA Islam","year":"2020","unstructured":"Islam MA et al (2020) Prevalence of antiphospholipid antibodies in Beh\u00e7et\u2019s disease: a systematic review and meta-analysis. PLoS ONE 15(1):e0227836","journal-title":"PLoS ONE"},{"key":"5112_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-025-04421-5","author":"SS Khandker","year":"2025","unstructured":"Khandker SS et al (2025) Global epidemiology of HIV among dialysis patients: a systematic review and meta-analysis. Int Urol Nephrol. https:\/\/doi.org\/10.1007\/s11255-025-04421-5","journal-title":"Int Urol Nephrol"},{"issue":"38","key":"5112_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039759","volume":"103","author":"S Zahra","year":"2024","unstructured":"Zahra S et al (2024) Prevalence of nephropathy among diabetic patients in North American region: a systematic review and meta-analysis. Medicine (Baltimore) 103(38):e39759","journal-title":"Medicine (Baltimore)"},{"issue":"44","key":"5112_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040339","volume":"103","author":"NA Shabbir","year":"2024","unstructured":"Shabbir NA et al (2024) Prevalence of HIV\/AIDS among pregnant women in North American region: a systematic review and meta-analysis. Medicine (Baltimore) 103(44):e40339","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"5112_CR42","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036933","volume":"103","author":"HB Mughal","year":"2024","unstructured":"Mughal HB et al (2024) Brain natriuretic peptide in acute heart failure and its association with glomerular filtration rate: a systematic review and meta-analysis. Medicine (Baltimore) 103(8):e36933","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"5112_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.ajic.2003.12.009","volume":"32","author":"AA Qadi","year":"2004","unstructured":"Qadi AA et al (2004) Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: a survey by serologic and molecular methods. Am J Infect Control 32(8):493\u2013495","journal-title":"Am J Infect Control"},{"key":"5112_CR44","doi-asserted-by":"publisher","unstructured":"Anwar, K., et al., Prevalence of Hepatitis B and Hepatitis C infection among patients undergoing dialysis. Journal of Human Virology and Retrovirology, 2016. 3(3):119-122 https:\/\/doi.org\/10.15406\/jhvrv.2016.03.00094","DOI":"10.15406\/jhvrv.2016.03.00094"},{"issue":"3","key":"5112_CR45","doi-asserted-by":"publisher","first-page":"672","DOI":"10.4103\/1319-2442.132236","volume":"25","author":"Z Lioussfi","year":"2014","unstructured":"Lioussfi Z et al (2014) Viral hepatitis C and B among dialysis patients at the Rabat University Hospital: prevalence and risk factors. Saudi J Kidney Dis Transplant 25(3):672\u2013679","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"5112_CR46","first-page":"22","volume":"4","author":"M Dibra","year":"2016","unstructured":"Dibra M et al (2016) Prevalence of hepatitis B and C in dialysis: a 4-year review in Albania. Int J Innov Res Technol Sci 4(1):22\u201326","journal-title":"Int J Innov Res Technol Sci"},{"issue":"1","key":"5112_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.21804\/25-1-5045","volume":"25","author":"L Mtingi-Nkonzombi","year":"2022","unstructured":"Mtingi-Nkonzombi L et al (2022) Prevalence of hepatitis B and vaccination response in patients with end-stage kidney disease on dialysis at a tertiary centre in the Eastern Cape province of South Africa. African J Nephrol 25(1):101\u2013107","journal-title":"African J Nephrol"},{"issue":"04","key":"5112_CR48","doi-asserted-by":"publisher","first-page":"75","DOI":"10.36346\/sarjbab.2023.v05i04.003","volume":"5","author":"ZS Ali","year":"2023","unstructured":"Ali ZS, Salman AD, Ali IA (2023) Prevalence of Hepatitis B Virus among renal dialysis patients in Diyala Province, Iraq. South Asian Res J Biol Appl Biosci 5(04):75\u201381","journal-title":"South Asian Res J Biol Appl Biosci"},{"issue":"2","key":"5112_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/AJOB\/2017\/31912","volume":"2","author":"M Ali","year":"2017","unstructured":"Ali M, Moftah H, Moftah S (2017) Hepatitis B Virus and Hepatitis C Virus in hemodialysis patients: a prevalence study from dialysis centers in El-Beyda and Almarj-Libya. Asian J Biol 2(2):1\u20135","journal-title":"Asian J Biol"},{"issue":"3","key":"5112_CR50","first-page":"316","volume":"61","author":"A Mazzoni","year":"1992","unstructured":"Mazzoni A, Innocenti M, Consaga M (1992) Retrospective study on the prevalence of B and non-A, non-B hepatitis in a dialysis unit: 17-year follow-up. Nephron 61(3):316\u2013317","journal-title":"Nephron"},{"key":"5112_CR51","doi-asserted-by":"publisher","unstructured":"Hardik, C., et al., Prevalence of Hepatitis B and Hepatitis C Infection among Patients Undergoing Dialysis. National Journal of Medical Research, 2022. 12(4)88-91https:\/\/doi.org\/10.55489\/njmr.13012023924.","DOI":"10.55489\/njmr.13012023924"},{"issue":"1","key":"5112_CR52","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3329\/birdem.v8i1.35038","volume":"8","author":"RM Hossain","year":"2018","unstructured":"Hossain RM et al (2018) Hepatitis B and Hepatitis C Virus infection among end stage renal disease patients on maintenance hemodialysis, their family members and dialysis staffs-a prevalence study. BIRDEM Med J 8(1):42\u201346","journal-title":"BIRDEM Med J"},{"issue":"5","key":"5112_CR53","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.20435","volume":"40","author":"GY Minuk","year":"2004","unstructured":"Minuk GY et al (2004) Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40(5):1072\u20131077","journal-title":"Hepatology"},{"issue":"8","key":"5112_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0135476","volume":"10","author":"E Kwon","year":"2015","unstructured":"Kwon E et al (2015) Differential effect of viral hepatitis infection on mortality among Korean maintenance dialysis patients: a prospective multicenter cohort study. PLoS ONE 10(8):e0135476","journal-title":"PLoS ONE"},{"issue":"1","key":"5112_CR55","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ndt\/14.1.40","volume":"14","author":"A Covic","year":"1999","unstructured":"Covic A (1999) Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 14(1):40\u201345","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"5112_CR56","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ndt\/12.1.180","volume":"12","author":"K Hung","year":"1997","unstructured":"Hung K et al (1997) Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: experience from Taiwan, an endemic area for Hepatitis B. Nephrol Dial Transplant 12(1):180\u2013183","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"5112_CR57","first-page":"184","volume":"23","author":"P Dentico","year":"1987","unstructured":"Dentico P et al (1987) Prevalence and occurrence of infections caused by Hepatitis B virus in the dialysis units in the Apulia region. Quad Sclavo Diagn Clin Lab 23(2):184\u2013200","journal-title":"Quad Sclavo Diagn Clin Lab"},{"issue":"4","key":"5112_CR58","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.4103\/jfmpc.jfmpc_1017_21","volume":"11","author":"D Raina","year":"2022","unstructured":"Raina D, Rawat N, Pandita AK (2022) Prevalence of Hepatitis B and Hepatitis C in patients undergoing hemodialysis at a teaching hospital in Uttarakhand. J Family Med Prim Care 11(4):1348\u20131353","journal-title":"J Family Med Prim Care"},{"issue":"1","key":"5112_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.5527\/wjn.v5.i1.101","volume":"5","author":"A Abou Rached","year":"2016","unstructured":"Abou Rached A et al (2016) Incidence and prevalence of Hepatitis B and Hepatitis C viruses in hemodialysis patients in Lebanon. World J Nephrol 5(1):101","journal-title":"World J Nephrol"},{"issue":"1","key":"5112_CR60","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12882-015-0010-z","volume":"16","author":"L Sowole","year":"2015","unstructured":"Sowole L et al (2015) The prevalence of occult Hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort. BMC Nephrol 16(1):12","journal-title":"BMC Nephrol"},{"key":"5112_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijregi.2022.09.004","volume":"5","author":"BAH Al-Masoodi","year":"2022","unstructured":"Al-Masoodi BAH et al (2022) Prevalence of occult hepatitis B virus infection among patients receiving haemodialysis in Sana\u2019a city. IJID Regions 5:141\u2013145","journal-title":"IJID Regions"},{"issue":"1","key":"5112_CR62","first-page":"1555775","volume":"2021","author":"MOO Jeele","year":"2021","unstructured":"Jeele MOO et al (2021) Prevalence and risk factors associated with Hepatitis B and Hepatitis C infections among patients undergoing hemodialysis: a single\u2010centre study in Somalia. Int J Nephrol 2021(1):1555775","journal-title":"Int J Nephrol"},{"issue":"1","key":"5112_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-12-265","volume":"12","author":"WA Alashek","year":"2012","unstructured":"Alashek WA, McIntyre CW, Taal MW (2012) Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infect Dis 12(1):265","journal-title":"BMC Infect Dis"},{"issue":"5","key":"5112_CR64","first-page":"475","volume":"12","author":"MD Musa","year":"2020","unstructured":"Musa MD, Ateya HK (2020) Prevalence of overt and occult Hepatitis B virus infections among 135 haemodialysis patients attending a haemodialysis centre at Al-Nasiriyah city, Iraq. Iran J Microbiol 12(5):475","journal-title":"Iran J Microbiol"},{"issue":"5","key":"5112_CR65","first-page":"1763","volume":"77","author":"S Gaber Ajeel","year":"2022","unstructured":"Gaber Ajeel S et al (2022) Contribution of Hepatitis B Contribution to Anemia in Dialysis Patients with Chronic Renal Failure. Iraq Arch Razi Inst 77(5):1763\u20131767","journal-title":"Iraq Arch Razi Inst"},{"issue":"5","key":"5112_CR66","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4269\/ajtmh.22-0345","volume":"108","author":"F Farshadpour","year":"2023","unstructured":"Farshadpour F, Taherkhani R, Shahabi A (2023) High prevalence of occult Hepatitis B virus infection among Iranian hemodialysis patients. Am J Trop Med Hyg 108(5):1017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"5112_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.nefroe.2016.04.004","volume":"36","author":"RG Agudo","year":"2016","unstructured":"Agudo RG et al (2016) Spanish multicentre PIBHE study: prevalence and immunisation of chronic Hepatitis B in haemodialysis patients in Spain. Nefrolog\u00eda (English Edition) 36(2):126\u2013132","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"3","key":"5112_CR68","first-page":"609","volume":"23","author":"J Etemadi","year":"2012","unstructured":"Etemadi J et al (2012) Prevalence and risk factors of Hepatitis B infection among hemodialysis patients in Tabriz: a multicenter report. Saudi J Kidney Dis Transpl 23(3):609\u2013613","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"3","key":"5112_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/jmv.23486","volume":"85","author":"Y Su","year":"2013","unstructured":"Su Y et al (2013) Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multicenter study in Beijing. China J Med Virol 85(3):425\u2013432","journal-title":"China J Med Virol"},{"key":"5112_CR70","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1590\/s0004-2803.201700000-34","volume":"54","author":"MNC Guimar\u00e3es","year":"2017","unstructured":"Guimar\u00e3es MNC, Facincani T, d. Santos SDS (2017) Hepatitis B status in hemodialysis patients. Arq Gastroenterol 54:356\u2013358","journal-title":"Arq Gastroenterol"},{"issue":"4","key":"5112_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.5812\/hepatmon.665","volume":"12","author":"MAA El Makarem","year":"2012","unstructured":"El Makarem MAA et al (2012) Prevalence of occult Hepatitis B virus infection in hemodialysis patients from Egypt with or without Hepatitis C virus infection. Hepat Mon 12(4):253","journal-title":"Hepat Mon"},{"issue":"1","key":"5112_CR72","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001278","volume":"70","author":"MJ Pereson","year":"2021","unstructured":"Pereson MJ et al (2021) Seroprevalence of Hepatitis B, Hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina. J Med Microbiol 70(1):001278","journal-title":"J Med Microbiol"},{"issue":"4","key":"5112_CR73","first-page":"681","volume":"20","author":"MA Assarehzadegan","year":"2009","unstructured":"Assarehzadegan MA et al (2009) Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran. Saudi J Kidney Dis Transplant 20(4):681\u2013684","journal-title":"Saudi J Kidney Dis Transplant"},{"issue":"1","key":"5112_CR74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1002\/jmv.22256","volume":"84","author":"GI Gasim","year":"2012","unstructured":"Gasim GI et al (2012) Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum. Sudan J Med Virol 84(1):52\u201355","journal-title":"Sudan J Med Virol"},{"issue":"15","key":"5112_CR75","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.7150\/ijms.49540","volume":"17","author":"Y Tang","year":"2020","unstructured":"Tang Y et al (2020) Occult Hepatitis B virus infection in maintenance hemodialysis patients: prevalence and mutations in \u201ca\u201d determinant. Int J Med Sci 17(15):2299","journal-title":"Int J Med Sci"},{"issue":"3","key":"5112_CR76","doi-asserted-by":"publisher","first-page":"317","DOI":"10.34172\/mejdd.2022.289","volume":"14","author":"SA Shamsdin","year":"2022","unstructured":"Shamsdin SA et al (2022) Prevalence of HBV, HCV, and HIV infections among patients undergoing hemodialysis in Fasa, Iran: a six-year follow-up study. Middle East J Dig Dis 14(3):317","journal-title":"Middle East J Dig Dis"},{"issue":"6","key":"5112_CR77","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/liv.13367","volume":"37","author":"C Isnard Bagnis","year":"2017","unstructured":"Isnard Bagnis C et al (2017) Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France. Liver Int 37(6):820\u2013826","journal-title":"Liver Int"},{"issue":"Suppl 3","key":"5112_CR78","first-page":"S219","volume":"5","author":"M Salehi","year":"2014","unstructured":"Salehi M et al (2014) Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan-Iran. Int J Prev Med 5(Suppl 3):S219","journal-title":"Int J Prev Med"},{"issue":"1","key":"5112_CR79","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1590\/S1517-838246120131195","volume":"46","author":"AY Takemoto","year":"2015","unstructured":"Takemoto AY et al (2015) Torque teno virus among dialysis and renal-transplant patients. Braz J Microbiol 46(1):307\u2013311","journal-title":"Braz J Microbiol"},{"key":"5112_CR80","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1590\/S0074-02762003000500003","volume":"98","author":"KP Souza","year":"2003","unstructured":"Souza KP et al (2003) Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Mem Inst Oswaldo Cruz 98:599\u2013603","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"5","key":"5112_CR81","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/S0272-6386(89)80019-8","volume":"13","author":"KN Lai","year":"1989","unstructured":"Lai KN et al (1989) Isolated presence of antibody to hepatitis B core antigen in dialysis patients: occurrence of subclinical hepatitis? Am J Kidney Dis 13(5):370\u2013376","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"5112_CR82","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1651-2227.1985.tb10952.x","volume":"74","author":"L Callis","year":"1985","unstructured":"Callis L et al (1985) Hepatitis B virus infection and vaccination in children undergoing hemodialysis. Acta Paediatr 74(2):213\u2013218","journal-title":"Acta Paediatr"},{"issue":"1","key":"5112_CR83","first-page":"860514","volume":"2013","author":"K Kosaraju","year":"2013","unstructured":"Kosaraju K et al (2013) Hepatitis viruses in heamodialysis patients: an added insult to injury? Hepat Res Treat 2013(1):860514","journal-title":"Hepat Res Treat"},{"issue":"3","key":"5112_CR84","first-page":"329","volume":"61","author":"E Franco","year":"1992","unstructured":"Franco E et al (1992) Control of hepatitis B virus infection in dialysis units in Latium, Italy. Nephron 61(3):329\u2013330","journal-title":"Nephron"},{"issue":"4","key":"5112_CR85","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/j.1440-1797.2007.00815.x","volume":"12","author":"V Thanachartwet","year":"2007","unstructured":"Thanachartwet V et al (2007) Viral hepatitis infections among dialysis patients: Thailand registry report. Nephrology Carlton 12(4):399\u2013405","journal-title":"Nephrology Carlton"},{"issue":"2","key":"5112_CR86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3349\/ymj.1998.39.2.116","volume":"39","author":"H Noh","year":"1998","unstructured":"Noh H et al (1998) Hepatitis G virus infection in hemodialysis and continuous ambulatory peritoneal dialysis patients. Yonsei Med J 39(2):116\u2013121","journal-title":"Yonsei Med J"},{"issue":"5\u20136","key":"5112_CR87","first-page":"465","volume":"70","author":"S Gohar","year":"1995","unstructured":"Gohar S et al (1995) Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients. J Egypt Public Health Assoc 70(5\u20136):465\u2013484","journal-title":"J Egypt Public Health Assoc"},{"issue":"7","key":"5112_CR88","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/BF01477279","volume":"58","author":"K Gmelin","year":"1980","unstructured":"Gmelin K et al (1980) Viral hepatitis A and B in hemodialysed patients. Klin Wochenschr 58(7):365\u2013370","journal-title":"Klin Wochenschr"},{"issue":"5","key":"5112_CR89","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1440-1797.2012.01603.x","volume":"17","author":"J Davies","year":"2012","unstructured":"Davies J et al (2012) Blood-borne viruses in the haemodialysis-dependent population attending Top End Northern Territory facilities 2000\u20132009. Nephrology Carlton 17(5):501\u2013507","journal-title":"Nephrology Carlton"},{"key":"5112_CR90","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1590\/S0036-46651998000500003","volume":"40","author":"SA Teles","year":"1998","unstructured":"Teles SA et al (1998) Hepatitis B virus infection profile in central Brazilian hemodialysis population. Rev Inst Med Trop Sao Paulo 40:281\u2013286","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"6","key":"5112_CR91","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2105\/AJPH.69.6.581","volume":"69","author":"GH Mayor","year":"1979","unstructured":"Mayor GH et al (1979) Prevalence of hepatitis B in 27 Michigan hemodialysis centers. Am J Public Health 69(6):581\u2013584","journal-title":"Am J Public Health"},{"issue":"2","key":"5112_CR92","doi-asserted-by":"publisher","first-page":"A4","DOI":"10.1016\/j.krcp.2014.05.023","volume":"33","author":"E Kwon","year":"2014","unstructured":"Kwon E et al (2014) Effect of hepatitis B and C virus infections on mortality in the Korean dialysis patients: a prospective multicenter cohort study. Kidney Res Clin Pract 33(2):A4\u2013A5","journal-title":"Kidney Res Clin Pract"},{"issue":"1","key":"5112_CR93","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cegh.2013.03.001","volume":"2","author":"S Prakash","year":"2014","unstructured":"Prakash S et al (2014) Prevalence of hepatitis B & C viruses among patients on hemodialysis in Lucknow, Uttar Pradesh. Clin Epidemiol Glob Health 2(1):19\u201323","journal-title":"Clin Epidemiol Glob Health"},{"issue":"1","key":"5112_CR94","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jceh.2013.02.003","volume":"3","author":"G Mittal","year":"2013","unstructured":"Mittal G et al (2013) Profile of hepatitis B virus, hepatitis C virus, hepatitis D virus and human immunodeficiency virus infections in hemodialysis patients of a tertiary care hospital in Uttarakhand. J Clin Exp Hepatol 3(1):24\u201328","journal-title":"J Clin Exp Hepatol"},{"issue":"5","key":"5112_CR95","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/0196-6553(95)90057-8","volume":"23","author":"N Petrosillo","year":"1995","unstructured":"Petrosillo N et al (1995) The risks of occupational exposure and infection by human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in the dialysis setting. Am J Infect Control 23(5):278\u2013285","journal-title":"Am J Infect Control"},{"issue":"3","key":"5112_CR96","first-page":"466","volume":"19","author":"ZR Khameneh","year":"2008","unstructured":"Khameneh ZR, Sepehrvand N (2008) Survey of hepatitis B status in hemodialysis patients in a training hospital in Urmia, Iran. Saudi J Kidney Dis Transpl 19(3):466\u2013469","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"5112_CR97","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12882-015-0117-2","volume":"16","author":"CM Duong","year":"2015","unstructured":"Duong CM et al (2015) Challenges of hemodialysis in Vietnam: experience from the first standardized district dialysis unit in Ho Chi Minh City. BMC Nephrol 16(1):122","journal-title":"BMC Nephrol"},{"issue":"1","key":"5112_CR98","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.patbio.2008.07.014","volume":"57","author":"D Rivanera","year":"2009","unstructured":"Rivanera D et al (2009) Prevalence of TT virus infection in Italian-dialysis patients. Pathol Biol (Paris) 57(1):97\u2013100","journal-title":"Pathol Biol (Paris)"},{"key":"5112_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.02.085","author":"P Zhang","year":"2010","unstructured":"Zhang P et al (2010) Impact of clinical condition at restarting dialysis on outcome after kidney allograft loss: a single-center experience. Transplant Proc. https:\/\/doi.org\/10.1016\/j.transproceed.2010.02.085","journal-title":"Transplant Proc"},{"issue":"3","key":"5112_CR100","first-page":"269","volume":"61","author":"P Carletti","year":"1992","unstructured":"Carletti P et al (1992) HBV infection in hemodialysis patients: monitoring and prevention. Nephron 61(3):269\u2013270","journal-title":"Nephron"},{"issue":"2","key":"5112_CR101","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1423-0410.1992.tb01177.x","volume":"62","author":"M Al Nasser","year":"1992","unstructured":"Al Nasser M et al (1992) Seropositivity to hepatitis C virus in Saudi haemodialysis patients. Vox Sang 62(2):94\u201397","journal-title":"Vox Sang"},{"issue":"3","key":"5112_CR102","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/0272-6386(95)90100-0","volume":"25","author":"B Dussol","year":"1995","unstructured":"Dussol B et al (1995) Hepatitis C virus infection among chronic dialysis patients in the south of France: a collaborative study. Am J Kidney Dis 25(3):399\u2013404","journal-title":"Am J Kidney Dis"},{"key":"5112_CR103","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1590\/S0036-46651995000100012","volume":"37","author":"B Vanderborght","year":"1995","unstructured":"Vanderborght B et al (1995) High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: a one-year follow-up study. Rev Inst Med Trop Sao Paulo 37:75\u201379","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"4","key":"5112_CR104","first-page":"248","volume":"33","author":"S Abu Samra","year":"1983","unstructured":"Abu Samra S et al (1983) Immunologic patterns in hemodialysis patients with and without HBV infection. Nephron 33(4):248\u2013252","journal-title":"Nephron"},{"issue":"1","key":"5112_CR105","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/ndt\/12.1.133","volume":"12","author":"F Fabrizi","year":"1997","unstructured":"Fabrizi F et al (1997) Hepatitis E virus infection in haemodialysis patients: a seroepidemiological survey. Nephrol Dial Transplant 12(1):133\u2013136","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"5112_CR106","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a116137","volume":"134","author":"J Hayashi","year":"1991","unstructured":"Hayashi J et al (1991) Prevalence of antibody to hepatitis C virus in hemodialysis patients. Am J Epidemiol 134(6):651\u2013657","journal-title":"Am J Epidemiol"},{"issue":"5","key":"5112_CR107","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/08860220701392074","volume":"29","author":"B-G Hsu","year":"2007","unstructured":"Hsu B-G et al (2007) TT virus infection in patients on peritoneal dialysis in Taiwan. Ren Fail 29(5):553\u2013557","journal-title":"Ren Fail"},{"issue":"5","key":"5112_CR108","first-page":"349","volume":"36","author":"S Jemni","year":"1994","unstructured":"Jemni S et al (1994) Seropositivity to hepatitis C virus in Tunisian haemodialysis patients. Nouv Rev Fr Hematol 36(5):349\u2013351","journal-title":"Nouv Rev Fr Hematol"},{"issue":"2","key":"5112_CR109","first-page":"280","volume":"16","author":"S Phanichphant","year":"1985","unstructured":"Phanichphant S, Mekswasdi P, Charuvichitratana J (1985) Hepatitis B virus infection in Thai hemodialysis patients. Southeast Asian J Trop Med Public Health 16(2):280\u2013284","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"1","key":"5112_CR110","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/08860220903391242","volume":"32","author":"T Sav","year":"2010","unstructured":"Sav T et al (2010) Occult HBV infection in continuous ambulatory peritoneal dialysis and hemodialysis patients. Ren Fail 32(1):74\u201377","journal-title":"Ren Fail"},{"issue":"2","key":"5112_CR111","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3748\/wjg.v16.i2.225","volume":"16","author":"P Mina","year":"2010","unstructured":"Mina P et al (2010) Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. World J Gastroenterol 16(2):225","journal-title":"World J Gastroenterol"},{"issue":"2","key":"5112_CR112","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/1096-9071(20000201)63:2<103::AID-JMV1003>3.0.CO;2-E","volume":"63","author":"JM L\u00f3pez\u2010Alcorocho","year":"2001","unstructured":"L\u00f3pez\u2010Alcorocho JM et al (2001) Prevalence of hepatitis B, hepatitis C, GB virus C\/hepatitis G and TT viruses in predialysis and hemodialysis patients. J Med Virol 63(2):103\u2013107","journal-title":"J Med Virol"},{"key":"5112_CR113","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1590\/S0074-02762006000600019","volume":"101","author":"RC Ferreira","year":"2006","unstructured":"Ferreira RC et al (2006) Hepatitis B virus infection profile in hemodialysis patients in central Brazil: prevalence, risk factors, and genotypes. Mem Inst Oswaldo Cruz 101:689\u2013692","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"5112_CR114","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/ijstd.IJSTD_53_17","volume":"40","author":"S Kansay","year":"2019","unstructured":"Kansay S, Sekhon J, Rana S (2019) Seroprevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among hemodialysis patients in a tertiary care teaching hospital in a developing country. Indian J Sex Transm Dis AIDS 40(2):120\u2013125","journal-title":"Indian J Sex Transm Dis AIDS"},{"issue":"5","key":"5112_CR115","doi-asserted-by":"publisher","first-page":"339","DOI":"10.5812\/hepatmon.5969","volume":"12","author":"MJ Zahedi","year":"2012","unstructured":"Zahedi MJ et al (2012) Seroprevalence of hepatitis viruses B, C, D and HIV infection among hemodialysis patients in Kerman Province, South-East Iran. Hepat Mon 12(5):339","journal-title":"Hepat Mon"},{"issue":"11","key":"5112_CR116","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/j.1365-2036.2005.02501.x","volume":"21","author":"F Fabrizi","year":"2005","unstructured":"Fabrizi F et al (2005) Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther 21(11):1341\u20131347","journal-title":"Aliment Pharmacol Ther"},{"key":"5112_CR117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.11604\/pamj.2017.27.235.13121","volume":"27","author":"HN Luma","year":"2017","unstructured":"Luma HN et al (2017) Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses among haemodialysis patients in two newly opened centres in Cameroon. Pan Afr Med J 27:235","journal-title":"Pan Afr Med J"},{"issue":"4","key":"5112_CR118","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5144\/0256-4947.1994.312","volume":"14","author":"SH Al-Dhahry","year":"1994","unstructured":"Al-Dhahry SH et al (1994) Hepatitis B, delta and human immunodeficiency virus infections among Omani patients with renal diseases: a seroprevalence study. Ann Saudi Med 14(4):312\u2013315","journal-title":"Ann Saudi Med"},{"issue":"2","key":"5112_CR119","first-page":"159","volume":"30","author":"G Bosevska","year":"2009","unstructured":"Bosevska G et al (2009) Screening for hepatitis b, c and hiv infection among patients on haemodialysis. Contribut Macedon Acad Sci Arts 30(2):159\u2013174","journal-title":"Contribut Macedon Acad Sci Arts"},{"issue":"4","key":"5112_CR120","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0168-8278(02)00457-9","volume":"38","author":"F Besisik","year":"2003","unstructured":"Besisik F et al (2003) Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 38(4):506\u2013510","journal-title":"J Hepatol"},{"issue":"3","key":"5112_CR121","first-page":"178","volume":"11","author":"F Joukar","year":"2011","unstructured":"Joukar F et al (2011) Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran: HCV and HBV seroprevalence in hemodialysis patients. Hepat Mon 11(3):178","journal-title":"Hepat Mon"},{"issue":"5","key":"5112_CR122","first-page":"1763","volume":"77","author":"S Gaber Ajeel","year":"2022","unstructured":"Gaber Ajeel S, Hasan Radhi S, Hadi Jebur M, Jasim Mohammad E (2022) Contribution of hepatitis B contribution to anemia in dialysis patients with chronic renal failure, Iraq. Arch Razi Inst 77(5):1763","journal-title":"Arch Razi Inst"},{"issue":"3","key":"5112_CR123","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S0272-6386(88)80151-3","volume":"11","author":"J Harnett","year":"1988","unstructured":"Harnett J et al (1988) The long-term outcome of hepatitis B infection in hemodialysis patients. Am J Kidney Dis 11(3):210\u2013213","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"5112_CR124","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/j.1440-1746.2005.03837.x","volume":"20","author":"PN Wong","year":"2005","unstructured":"Wong PN et al (2005) Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol 20(11):1641\u20131651","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"5112_CR125","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.7359","volume":"12","author":"AE Grzegorzewska","year":"2012","unstructured":"Grzegorzewska AE (2012) Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients. Hepat Mon 12(11):e7359","journal-title":"Hepat Mon"},{"issue":"2","key":"5112_CR126","doi-asserted-by":"publisher","first-page":"270","DOI":"10.4254\/wjh.v7.i2.270","volume":"7","author":"GI Gasim","year":"2015","unstructured":"Gasim GI, Bella A, Adam I (2015) Immune response to hepatitis B vaccine among patients on hemodialysis. World J Hepatol 7(2):270","journal-title":"World J Hepatol"},{"issue":"10","key":"5112_CR127","volume":"12","author":"W Elahi","year":"2020","unstructured":"Elahi W et al (2020) Hepatitis B and C infections in patients with prolonged hemodialysis secondary to chronic renal failure. Cureus 12(10):e10905","journal-title":"Cureus"},{"issue":"2","key":"5112_CR128","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1440-1797.2009.01268.x","volume":"15","author":"M Edey","year":"2010","unstructured":"Edey M, Barraclough K, Johnson DW (2010) Hepatitis B and dialysis. Nephrology Carlton 15(2):137\u2013145","journal-title":"Nephrology Carlton"},{"key":"5112_CR129","volume-title":"Seminars in nephrology","author":"H Puttinger","year":"2002","unstructured":"Puttinger H, Vychytil A (2002) Hepatitis B and C in peritoneal dialysis patients. Seminars in nephrology. Elsevier"},{"issue":"2","key":"5112_CR130","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/S0272-6386(99)70312-4","volume":"33","author":"ER Miller","year":"1999","unstructured":"Miller ER, Alter MJ, Tokars JI (1999) Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 33(2):356\u2013360","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"5112_CR131","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1053\/j.ajkd.2003.08.020","volume":"42","author":"AF Charest","year":"2003","unstructured":"Charest AF et al (2003) Evolution of naturally acquired hepatitis B immunity in the long-term hemodialysis population. Am J Kidney Dis 42(6):1193\u20131199","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5112_CR132","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2445283","volume":"21","author":"L Ding","year":"2025","unstructured":"Ding L, Huang J, Huang S (2025) The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus. Hum Vaccin Immunother 21(1):2445283","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"5112_CR133","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.nefroe.2020.08.005","volume":"41","author":"F Fabrizi","year":"2021","unstructured":"Fabrizi F et al (2021) Hepatitis B virus vaccine and chronic kidney disease. The advances. Nefrolog\u00eda (English Edition) 41(2):115\u2013122","journal-title":"Nefrolog\u00eda (English Edition)"},{"issue":"5","key":"5112_CR134","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4254\/wjh.v7.i5.761","volume":"7","author":"D Sit","year":"2015","unstructured":"Sit D et al (2015) Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy. World J Hepatol 7(5):761","journal-title":"World J Hepatol"},{"key":"5112_CR135","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0168-8278(03)00152-1","volume":"39","author":"D Shouval","year":"2003","unstructured":"Shouval D (2003) Hepatitis B vaccines. J Hepatol 39:70\u201376","journal-title":"J Hepatol"},{"key":"5112_CR136","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7201a1","author":"EE Conners","year":"2023","unstructured":"Conners EE (2023) Screening and testing for Hepatitis B virus infection: CDC recommendations\u2014United States, 2023. MMWR Recomm Rep. https:\/\/doi.org\/10.15585\/mmwr.rr7201a1","journal-title":"MMWR Recomm Rep"},{"key":"5112_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2025.199567","volume":"355","author":"Z Pu","year":"2025","unstructured":"Pu Z et al (2025) HBsAg and anti-HBs coexistence in patients with HBV in acute and chronic phases. Virus Res 355:199567","journal-title":"Virus Res"},{"issue":"1","key":"5112_CR138","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/jcm9010202","volume":"9","author":"F Moretto","year":"2020","unstructured":"Moretto F et al (2020) Isolated anti-HBc: significance and management. J Clin Med 9(1):202","journal-title":"J Clin Med"},{"key":"5112_CR139","unstructured":"CFD Control and Prevention, Clinical Testing and Diagnosis for Hepatitis B. Accessed June, 2024. 26."},{"key":"5112_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105975","volume":"230","author":"G Ye","year":"2024","unstructured":"Ye G et al (2024) Anti-HBc mirrors the activation of HBV-specific CD8+ T cell immune response and exhibits a direct effect on HBV control. Antiviral Res 230:105975","journal-title":"Antiviral Res"},{"issue":"3","key":"5112_CR141","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s12072-009-9140-3","volume":"3","author":"Y-F Liaw","year":"2009","unstructured":"Liaw Y-F (2009) HBeAg seroconversion as an important end point in the treatment of chronic hepatitis B. Hepatol Int 3(3):425\u2013433","journal-title":"Hepatol Int"},{"issue":"3","key":"5112_CR142","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1515\/mr-2024-0022","volume":"4","author":"SA Hudu","year":"2024","unstructured":"Hudu SA, Shinkafi SaH, Jimoh AO (2024) A critical review of diagnostic and prognostic markers of chronic Hepatitis B infection. Med Rev 4(3):225\u2013234","journal-title":"Med Rev"},{"issue":"1","key":"5112_CR143","doi-asserted-by":"publisher","first-page":"2534079","DOI":"10.1080\/21505594.2025.2534079","volume":"16","author":"R Xue","year":"2025","unstructured":"Xue R et al (2025) Prevalence and clinical significance of HBeAg-positive chronic hepatitis B patients with and without anti-HBe antibody. Virulence 16(1):2534079","journal-title":"Virulence"},{"issue":"5","key":"5112_CR144","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/0016-5085(86)90395-1","volume":"90","author":"F Bonino","year":"1986","unstructured":"Bonino F et al (1986) Chronic hepatitis in HBsAg carriers with serum HBV-DNA and anti-HBe. Gastroenterology 90(5):1268\u20131273","journal-title":"Gastroenterology"},{"issue":"10","key":"5112_CR145","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.3109\/0886022X.2010.517354","volume":"32","author":"C Wang","year":"2010","unstructured":"Wang C et al (2010) Hepatitis B virus infection and related factors in hemodialysis patients in China\u2013systematic review and meta-analysis. Ren Fail 32(10):1255\u20131264","journal-title":"Ren Fail"},{"issue":"3","key":"5112_CR146","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1515\/jtim-2015-0018","volume":"3","author":"B Bernieh","year":"2015","unstructured":"Bernieh B (2015) Viral hepatitis in hemodialysis: an update. J Transl Intern Med 3(3):93\u2013105","journal-title":"J Transl Intern Med"},{"issue":"6","key":"5112_CR147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251570","volume":"16","author":"T Adane","year":"2021","unstructured":"Adane T, Getawa S (2021) The prevalence and associated factors of hepatitis B and C virus in hemodialysis patients in Africa: a systematic review and meta-analysis. PLoS ONE 16(6):e0251570","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"5112_CR148","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1136\/gut.38.Suppl_2.S48","volume":"38","author":"J Torres","year":"1996","unstructured":"Torres J (1996) Hepatitis B and hepatitis delta virus infection in South America. Gut 38(Suppl 2):S48\u2013S55","journal-title":"Gut"},{"issue":"1","key":"5112_CR149","first-page":"9","volume":"1","author":"FH Pujol","year":"2016","unstructured":"Pujol FH et al (2016) Hepatitis B occult infection in indigenous populations from Latin America. JSM Hepat 1(1):9","journal-title":"JSM Hepat"},{"issue":"2","key":"5112_CR150","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11901-010-0042-6","volume":"9","author":"TM Chan","year":"2010","unstructured":"Chan TM (2010) Hepatitis B and renal disease. Curr Hepat Rep 9(2):99\u2013105","journal-title":"Curr Hepat Rep"},{"key":"#cr-split#-5112_CR151.1","unstructured":"Alter, MJ, et al (2001)Recommendations for preventing transmission of infections among chronic hemodialysis patients. EBSCO"},{"key":"#cr-split#-5112_CR151.2","unstructured":"MMWR: Morbidity & Mortality Weekly Report 2001, vol 50, issue 16, p 1"},{"issue":"45","key":"5112_CR152","doi-asserted-by":"publisher","first-page":"6037","DOI":"10.3748\/wjg.v13.i45.6037","volume":"13","author":"Y-L Cao","year":"2007","unstructured":"Cao Y-L, Wang S-X, Zhu Z-M (2007) Hepatitis B viral infection in maintenance hemodialysis patients: a three year follow-up. World J Gastroenterol 13(45):6037","journal-title":"World J Gastroenterol"},{"issue":"1","key":"5112_CR153","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12882-019-1529-1","volume":"20","author":"E Garthwaite","year":"2019","unstructured":"Garthwaite E et al (2019) Clinical practice guideline management of blood borne viruses within the haemodialysis unit. BMC Nephrol 20(1):388","journal-title":"BMC Nephrol"},{"key":"5112_CR154","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139x.2012.01089.x","author":"YC Tanhehco","year":"2012","unstructured":"Tanhehco YC, Berns JS (2012) Red blood cell transfusion risks in patients with end\u2010stage renal disease. Semin Dial. https:\/\/doi.org\/10.1111\/j.1525-139x.2012.01089.x. (Wiley Online Library)","journal-title":"Semin Dial"},{"issue":"5","key":"5112_CR155","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.bjid.2015.04.003","volume":"19","author":"RC Wahle","year":"2015","unstructured":"Wahle RC et al (2015) Hepatitis B virus reactivation after treatment for hepatitis C in hemodialysis patients with HBV\/HCV coinfection. Braz J Infect Dis 19(5):533\u2013537","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"5112_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275238","volume":"17","author":"S Palomo-Pi\u00f1\u00f3n","year":"2022","unstructured":"Palomo-Pi\u00f1\u00f3n S et al (2022) Prevalent coinfection and associated factors for hepatitis b, hepatitis c, and human immunodeficiency virus in patients submitted to renal replacement therapy: a cross-sectional study of 21 dialysis units in the State of Mexico. PLoS ONE 17(12):e0275238","journal-title":"PLoS ONE"},{"issue":"1","key":"5112_CR157","doi-asserted-by":"publisher","first-page":"25","DOI":"10.21037\/atm-21-6272","volume":"10","author":"J Cai","year":"2022","unstructured":"Cai J et al (2022) Prevalence and clinical characteristics of hepatitis B surface antigen-negative\/hepatitis B core antibody-positive patients with detectable serum hepatitis B virus DNA. Ann Transl Med 10(1):25","journal-title":"Ann Transl Med"},{"issue":"9","key":"5112_CR158","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/v14091936","volume":"14","author":"SA Kazmi","year":"2022","unstructured":"Kazmi SA et al (2022) Hepatitis B among university population: Prevalence, associated risk factors, knowledge assessment, and treatment management. Viruses 14(9):1936","journal-title":"Viruses"},{"key":"5112_CR159","volume":"20","author":"UD Abazuh","year":"2023","unstructured":"Abazuh UD et al (2023) Detection and prevalence of HBsAg and HBV DNA among visiting patients attending health facilities in Nigeria. Sci Afr 20:e01702","journal-title":"Sci Afr"},{"issue":"11","key":"5112_CR160","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta\u2010analysis. Stat Med 21(11):1539\u20131558","journal-title":"Stat Med"},{"issue":"5","key":"5112_CR161","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/17571774241239777","volume":"25","author":"M Butsashvili","year":"2024","unstructured":"Butsashvili M et al (2024) Hepatitis b and hepatitis c testing practices and observed seroconversions among dialysis facilities in Georgia. J Infect Prev 25(5):182\u2013187","journal-title":"J Infect Prev"},{"issue":"3","key":"5112_CR162","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1053\/j.ackd.2019.03.003","volume":"26","author":"V Soi","year":"2019","unstructured":"Soi V, Soman S (2019) Preventing hepatitis B in the dialysis unit. Adv Chronic Kidney Dis 26(3):179\u2013184","journal-title":"Adv Chronic Kidney Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05112-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05112-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:24Z","timestamp":1789635804000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05112-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":163,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5112"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05112-5","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]},"assertion":[{"value":"11 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}